Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-17
2005-05-17
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S202000
Reexamination Certificate
active
06894064
ABSTRACT:
This invention provides compounds of formula Iand pharmaceutically acceptable salts and solvates thereof, characterized that the compound is in particulate form and having a specific size range.The present invention further provides pharmaceutical compositions containing or formulated using compounds of formula I, and the use of such compounds for alleviating human pathologies, including osteoporosis, serum lipid lowering, and breast cancer.
REFERENCES:
patent: 4133814 (1979-01-01), Jones et al.
patent: 4380635 (1983-04-01), Peters
patent: 4391755 (1983-07-01), Wang et al.
patent: 4418068 (1983-11-01), Jones
patent: 4515805 (1985-05-01), Newman
patent: 4605517 (1986-08-01), Riley et al.
patent: 5202129 (1993-04-01), Samejima et al.
patent: 5441964 (1995-08-01), Bryant et al.
patent: 5494920 (1996-02-01), Glasebrook et al.
patent: 5494929 (1996-02-01), Grese
patent: 5532254 (1996-07-01), Bowling
patent: 5629425 (1997-05-01), Labell et al.
patent: 5731327 (1998-03-01), Luke
patent: 6458811 (2002-10-01), Arbuthnot et al.
patent: 2141999 (1995-09-01), None
patent: 2158399 (1996-03-01), None
patent: 108606 (1983-11-01), None
patent: 605193 (1993-12-01), None
patent: 670162 (1995-02-01), None
patent: 674903 (1995-10-01), None
patent: 2097788 (1982-11-01), None
patent: 2293382 (1996-03-01), None
Webster's II dictionary, p. 286 (1984).*
Nystrom et al. “Comparison of permeametry and photometry for the measurement of . . . ” CA 88:126272 (1978).*
Pharmaceutics: The Science of Dosage Form Design, Churchill Livingston, New York, NY, Chapters 1 and 13, (1988).
Remington's Pharmaceutical Sciences, 18thEd., Mack Publishing Company, Eaton, PA, Chapters 19, 31 and 89, (1990).
Barr Laboratories, Inc. Oct. 1, 2004 Paragraph IV Certification Letter to Eli Lilly & Company Re: U.S. Appl. No. 6,797,719.
Textbook of Pharmacology, Second Edition, p. 40.9 (1980), W. C. Bowman et al., Blackwell Scientific Publications.
Lieberman, et al., “Pharmaceutical Dosage Forms” Marcel Dekker Inc., p107-117, 186-187, 1980.
Omelczuk, et al., “Influence of micronization on the compaction properties of an investigational drug using tableting index analysis” Eur. J. Pharm. Biopharm., v. 43, 95-1 OC., 1997.
West, “Blocky Diamond Particles from Diamond Powder” CA 73:57576.
Jones, J. Med. Chem., 27:1057-1066, 1984.
Pharmaceutics, Chief Editor: Mr. XiNiao Zhu, the People's Health Publishers, third edition, Jul. 1994.
Arbuthnot Gordon Nelson
Dalder Brian Weston
Hartauer Kerry John
Luke Wayne Douglas
Stratford, Jr. Robert Eugene
Chang Celia
Eli Lilly and Company
Sales James J.
Voy Gilbert T.
LandOfFree
Benzothiophenes, formulations containing same, and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzothiophenes, formulations containing same, and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzothiophenes, formulations containing same, and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3429859